Most Recent

image: Opinion: Understanding and Coping With Rising Publication Costs

Opinion: Understanding and Coping With Rising Publication Costs

By M. Bishr Omary and Theodore S. Lawrence | September 1, 2017

As article processing charges top $5,000 at some research journals, authors and institutions have means of negotiating better deals or finding less expensive options.

0 Comments

image: Opinion: Why I Published in a Predatory Journal

Opinion: Why I Published in a Predatory Journal

By John H. McCool | April 6, 2017

Our totally bogus case report swiftly passed muster, with only minor revisions requested.

12 Comments

image: Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

By John D. Loike and Jennifer Miller | February 1, 2017

What can be done to lower development costs and drug prices?

4 Comments

image: Opinion: Ethical Considerations of “Three-Parent” Babies

Opinion: Ethical Considerations of “Three-Parent” Babies

By John D. Loike and Nancy Reame | December 22, 2016

Mitochondrial replacement therapy raises important societal and ethical concerns, but should be embraced for its utility in preventing disease.

0 Comments

image: The Age of Pharmabrewing

The Age of Pharmabrewing

By Laura Marengo and John D. Loike | January 1, 2016

We should not resist developing opiate-producing GM yeast for fear of the technology falling into the wrong hands.

0 Comments

image: When Does a Smart Mouse Become Human?

When Does a Smart Mouse Become Human?

By John D. Loike | July 1, 2015

Ethical issues attend the creation of animal-human chimeras.

1 Comment

image: Control ALT, Delete Cancer

Control ALT, Delete Cancer

By Haroldo Silva, David Halvorsen, and Jeremy D. Henson | April 1, 2015

Treating cancer by shutting down the alternative lengthening of telomeres (ALT) pathway

1 Comment

image: Enhanced Enhancers

Enhanced Enhancers

By Eric Olson | November 1, 2014

The recent discovery of super-enhancers may offer new drug targets for a range of diseases.

0 Comments

image: Wild Relatives

Wild Relatives

By Colin K. Khoury, Hannes Dempewolf, and Nora P. Castañeda-Álvarez | June 1, 2014

As rich sources of genetic diversity, the progenitors and kin of today’s food crops hold great promise for improving production in agriculture’s challenging future.

1 Comment

image: Remaking Nature

Remaking Nature

By Kent H. Redford | August 1, 2013

Synthetic biologists need to work together with conservationists to understand the environmental consequences of this new technology.

6 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Probiotics Prevent Cholera in Animal Models